Literature DB >> 19074668

Prosthetic valve endocarditis caused by Pseudomonas mosselii.

Elizabeth McLellan1, David Partridge1.   

Abstract

We describe a case of Pseudomonas mosselii prosthetic valve endocarditis that was successfully treated with antibiotic therapy in the absence of valve replacement. P. mosselii is a highly unusual cause of endocarditis and there are few case reports of curative treatment of pseudomonal prosthetic valve endocarditis with antibiotics alone.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19074668     DOI： 10.1099/jmm.0.005553-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  4 in total

1.  VIM-1-producing Pseudomonas mosselii isolates in Italy, predating known VIM-producing index strains.

Authors:  Tommaso Giani; Anna Marchese; Erika Coppo; Vesselina Kroumova; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.

Authors:  Sylvie Mazurier; Annabelle Merieau; Dorian Bergeau; Victorien Decoin; Daniel Sperandio; Alexandre Crépin; Corinne Barbey; Katy Jeannot; Maïté Vicré-Gibouin; Patrick Plésiat; Philippe Lemanceau; Xavier Latour
Journal:  Appl Environ Microbiol       Date:  2015-01-30       Impact factor: 4.792

3.  Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations.

Authors:  Christian Damgaard; Karin Magnussen; Christian Enevold; Martin Nilsson; Tim Tolker-Nielsen; Palle Holmstrup; Claus Henrik Nielsen
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

4.  Cytotoxicity and inflammatory potential of two Pseudomonas mosselii strains isolated from clinical samples of hospitalized patients.

Authors:  Charlène Leneveu-Jenvrin; Amar Madi; Emeline Bouffartigues; Kelly Biaggini; Marc Feuilloley; Sylvie Chevalier; Nathalie Connil
Journal:  BMC Microbiol       Date:  2013-05-29       Impact factor: 3.605
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.